RESULTS There was a significant improvement of TIMI-3 flow, TMP-0w1 and CTFC after intracoronary administration of verapamil (89.9% vs 37.2%, p <0.001; 76.0% vs 11.6%, p <0.001; 66AE27 frames vs 37AE21 frames, p <0.001, respectively). At end of the procedure, TIMI 3 flow was achieved in 114 patients (88.4%), TMP 2w3 flow in 98 patients (76.0%). The rate for complete, partial and no ST segment resolution was 31.6%, 26.3% and 42.1%, respectively. Transient complete atrioventricular block occurred during verapamil injection to right coronary artery in 2 patients, which disappeared after atropine. There was no MACE in-hospital and 30-day except for 1 patient died of cardiogenic shock in hospital.
CONCLUSIONS Intracoronary verapamil via self-made perfusion balloon is an effective, safe treatment of NSF associated with PCI in ACS patients.
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Safety and Efficacy of using a single transRAdial MAC guiding catheter for coronary angiograPhy and Intervention in patients with STE-MyocarDial infarction (RAPID) Jincheng Guo, Wenming Chen, Guozhong Wang, Rong Xu, Zijing Liu, Shunjin Gan, Libin Zhang Beijing Luhe hospital, Capital Medical University OBJECTIVES Coronary intervention using transradial approach is common worldwide. It is normally necessary to use one diagnostic catheter and guiding catheter in primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI). It is unknown whether using a single guiding catheter for both nonculprit and culprit vessel angiography and intervention during transradial primary PCI is feasible. The aim of this study is to investigate the safety and feasibility of using a single guiding catheter (MAC 3.5) for left and right coronary angiography and intervention in patients with STEMI.
METHODS This was a single-center, prospective, randomized study conducted from August 2011 to April 2014, 360 patients with STEMI indicated for transradial primary PCI performed were randomized into two groups: MAC group (180 cases) consisted of patients who underwent coronary angiography and primary PCI by using a single guiding catheter (MAC3.5). Control group (180 cases) included patients who first underwent coronary angiography with 5FTiger diagnostic catheter followed by guiding catheter selection at the operator's discretion for intervention. The primary outcomes were catheterization laboratory door to balloon time (C2B). The secondary outcomes were major adverse cardiac events (MACE) including composite of cardiac death, myocardial infarction target vessel revascularization, target lesion revascularization and stent thrombosis at 30 days and 6 months. Analyses were by intention to treat.
RESULTS Baseline patient characteristics were similar between the MAC group and control group. the sheath placement time (2.2AE1.8 min vs 1.7AE1.3 min), the PCI procedural success rate(91.7% vs 91.7%), door to balloon time(87.1AE39.4 min vs 85.6AE35.0 min) and contrast consumption (103AE37 ml vs 110AE41 ml) in the two groups were not statistically significant(p >0.05). Compare with the Control group, C2B time, total procedure time and the overall fluoroscopy time were significantly lower in MAC Group (17.1AE5.5 min vs 18.64AE 4.20 min, p<0.001; 32.1AE15.4 min vs 35.9AE12.9 min, p ¼0.013; 8.9 AE3.8min vs 9.9 AE4.8 min, p ¼0.032, respectively). The 30-day MACE rates were 2.8% and 2.2% in the MAC and control groups (p >0.05). No significant difference in MACE was observed at 6-month (5.6% vs 5.0%, p >0.05).
CONCLUSIONS A single transradial MAC 3.5 guiding catheter for coronary angiography and intervention seems to be a better option for patients with STEMI for whom primary PCI is planned. It can shorten C2B time, procedure time and fluoroscopy time. Further study is required to determine whether this strategy can favorably affect clinical outcomes.
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Establishment of an experimental angiographic slow coronary flow model by microsphere embolism in pigs METHODS In closed chest porcine, slow reflow was established in 8 pigs by repeated small amount left anterior descending coronary injection of 40 mm microsphere injection till the appearance of angiographic slow flow: Thrombolysis in Myocardial Infarction (TIMI) frame count (TFC)>40. TFC and TIMI myocardial perfusion grade (TMPG) were determined in coronary angiography examinations (CAG). CAG and left ventriculography were repeated at 4 weeks post procedure.
RESULTS
One pig died at 2 days post microsphere injection and autopsy evidenced lung edema in this animal, another pig received temporary mechanical ventilation due to breathing depression post anesthesia and recovered. TFC was significantly increased at the time of establishment of no-reflow compared to baseline (59.8AE19.4 vs. 15.8AE3.4, p<0.05) and returned to baseline value (18.2AE2.3) at 4 weeks post procedure. Left ventricular (LV) end-diastolic volume (32.8AE4.2 vs. 24.4AE3.7 ml, p<0.05) and LV end-diastolic pressure (14.3AE1.2 vs. 7.8AE3.6mmHg, p<0.05) were higher, LV systolic pressure (123AE9 vs. 147AE15mmHg, p<0.05) and ejection fraction (58AE5 vs. 68AE5%, p<0.05) were lower at 4 weeks post procedure compared to baseline values.
CONCLUSIONS Angiographic no-reflow could be reliably induced in porcine by coronary microsphere injection. This model may support investigation on underlying mechanisms and new therapy options for slow flow phenomenon. OBJECTIVES This study aimed at comparing the long-term (>5 years) outcomes of patients with unprotected left main coronary artery (ULMCA) disease underwent percutaneous coronary intervention (PCI) with drug-eluting stents (DES) and coronary-artery bypass grafting (CABG).
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METHODS All consecutive patients with ULMCA disease treated with DES implantation versus CABG in our center, between January 2003 to July 2009, were screened for analyzing. A propensity score analysis 
